QR-koodi

Endocan is a key player in cardiovascular disease: A review

In recent years, the attention of scientists has been actively focused on studying the role of endocan as a biological marker of endothelial dysfunction in cardiovascular diseases. Until recent years, endocan has been studied in acute kidney injury, chronic kidney disease, and renal replacement ther...

Täydet tiedot

Tallennettuna:
Päätekijät: Amina M. Alieva, Elena V. Reznik, Irina E. Baykova, Natalia V. Teplova, Liudmila M. Makeeva, Kira V. Voronkova, Nyurzhanna Kh. Khadzhieva, Anna V. Modestova, Gaiane G. Totolyan, Ramiz K. Valiev, Alexander M. Li, Irina A. Kotikova, Igor G. Nikitin
Aineistotyyppi: Artigo
Kieli:Russo
Julkaistu: ZAO "Consilium Medicum" 2023-05-01
Sarja:Consilium Medicum
Aiheet:
biological markers
endocan
atherosclerosis
arterial hypertension
acute coronary syndrome
myocardial infarction
heart failure
Linkit:https://consilium.orscience.ru/2075-1753/article/viewFile/409706/124828
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia